Recent Videos

The COVID-19 Vaccination - What do Canadian Oncologists need to Know?

Featuring:
Dr. Lynora Saxinger
Dr. Leta Forbes
Dr. Sebastien Hotte
Dr. Alina Gerrie
Chair:
Dr Scott Berry
Dr. Sharlene Gill

Breast Cancer

Featuring:
Dr. Nancy Nixon

Palliative Care

Featuring:
Dr. Jessica Simon

Adjuvant HER2+ Therapy Treatment Landscape – Clinician Experience & Insights

Featuring:
Dr. Francis Arena

SBRT Update/Oligometastases

Featuring:
Dr. David Palma

Optimizing metastatic HER2+ therapy – what are the treatment considerations?

Featuring:
Dr. Christine Brezden-Masley

“ALL”-Hands: bridging ALL care between peds, AYAs, and adults

Featuring:
Dr. Stacey Cooper
Dr. Dan Douer
Dr. Sumit Gupta
Dr. Julie Bergeron
Chair:
Dr. Andre Schuh

Expert insights on current clinical data for optimal management of patients with HER2-positive MBC

Featuring:
Dr. Reshma Mahtani
Chair:
Dr. Sandeep Sehdev

Lunch Symposium (Mylan) - The Future of Biosimilars in Oncology - Implementing the Lessons from Today

Featuring:
Dr. Stephen Chia

Radiation Oncology Update: Management of Oligometastases

Featuring:
Dr. Alexander Louie

Breast Cancer

Featuring:
Dr. Katarzyna Jerzak

Updates and Optimizing Outcomes in Non Intensive AML Management

Featuring:
Dr. Jorge Cortes
Chair:
Dr. Brian Leber

Optimizing Patient Outcomes for HER2+ Early Breast Cancer

Featuring:
Dr. Anil Joy
Dr. Olexiy Aseyev
Dr. Angel Arnaout
Alia Thawer
Chair:
Dr. Sonal Gandhi

Critical Role of Treating Minimal Residual Disease in Acute Lymphoblastic Leukemia

Featuring:
Dr. Nikola Gokbuget
Chair:
Dr. Andre Schuh

A Decade of Systemic Treatments of Hepatocellular Carcinoma: From a Myth to a Central Role

Featuring:
Dr. Ghassan Abou-Alfa
Chair:
Dr. Sharlene Gill

Drug development in Immuno-Oncology

Featuring:
Dr. Jason Luke

Biomarkers in Immuno-Oncology

Featuring:
Dr. Rosalyn Juergens

Cellular Therapies: Clinical Overview

Featuring:
Dr. Michael Chu

Cellular Therapies: Production and Challenges

Featuring:
Dr. Brad Nelson

Cellular Therapies: Q&A

Featuring:
Dr. Michael Chu and Dr. Brad Nelso

Breast Cancer

Featuring:
Dr. Sara Soldera

Common Adverse-Events

Featuring:
Dr. Ralph Wong

Uncommon Adverse-Events

Featuring:
Dr. Jose Monzon

Implementation of Biosimilars in Clinical Practice: Cost, Ethics, and Nuances

Featuring:
Dr. Scott Berry
Dr. Christine Brezden-Masley
Dr. Stephen Chia
Dr. John Hilton
Dr. Scott Edwards
Swanee Tobin

The evolving treatment landscape of advanced cSCC

Featuring:
Dr. Teresa Petrella
Chair:
Dr. Gary Groot

Defining the Standard of Care in NSCLC

Featuring:
Dr. Marina Garassino
Dr. Randeep Sangha

IMpassion130, IMpassion131, IMpassion031 and ASCENT

TNBC
Featuring:
Dr. Heather McArthur
Dr. Fabrice André
Dr. Erika Hamilton

Monarch E and PALLAS

Early HR+
Featuring:
Dr. Heather McArthur
Dr. Fabrice André
Dr. Erika Hamilton

SOLAR-1 and nextMONARCH

HR+ MBC
Featuring:
Dr. Heather McArthur
Dr. Fabrice André
Dr. Erika Hamilton

Disparities in Cancer during the COVID-19 Pandemic: CCOS Study

Featuring:
Dr. Sheena Bhalla

NeoTRIPaPDL1 trial

Featuring:
Dr. Giampaolo Bianchini

A multi-disciplinary approach to the evolving landscape of advanced cSCC

Featuring:
Dr. Scott Ernst
Dr. Ian Poon
Dr. Kathryn Roth
Dr. David Zloty

Impact of COVID-19 on management of cancer treatments & psychological consequence for patients

Featuring:
Dr. Florence Joly

EICAM/2014-12 (FLIPPER) study

Featuring:
Dr. Joan Albanell

IMpassion130 study

Featuring:
Dr. Leisha Emens

SOLAR-1 study

Featuring:
Dr. Fabrice André

nextMONARCH

Featuring:
Dr. Erika P. Hamilton

Abemaciclib in high risk early breast cancer

Featuring:
Dr. Stephen R. Johnston

IMpassion031 Study

Featuring:
Dr. Nadia Harbeck

ADAPT-TP survival results

Featuring:
Dr. Nadia Harbeck

ASCENT study

Featuring:
Dr. Aditya Bardia

PALLAS Trial

Featuring:
Dr. Erica L. Mayer

Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection (COVID-19 Data)

Featuring:
Dr. Trisha Wise-Draper

Clinical & lab prognostic factors in patients with cancer and SARS-CoV-2 infection: CCC19

Featuring:
Dr. Petros Grivas

The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLAA

Featuring:
Dr. Pia Kvistborg

The Impact of COVID-19 on Oncology Professionals: Initial Results of The ESMO Resilience Task Force Survey Collaboration

Featuring:
Dr Susana Banerjee

Outcome and prognostic factors of SARS CoV-2 infection in cancer patients

Featuring:
Dr. Markus Joerger

ESMO 2020 Virtual Data Watch - Breast Cancer

Application of Biosimilars in Clinical Care: Potential Opportunities and Barriers

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Sandeep Sehdev

Debate: What is the optimal endpoint in adjuvant lung cancer trials evaluating target treatments?

Featuring:
Dr. Roy Herbst &
Dr. Jack West
Chair:
Dr. Frances Shepherd

Real World Experience in the EU with Biosimilars

Featuring:
Dr. Cornelius Waller
Chair:
Dr. Bruce Colwell

Panel Discussion: Does the Primary Matter? - Moving Towards a Tumour-Agnostic Approach

Featuring:
Dr. Gwyn Bebb
Dr. Stephen Yip
Dr. Janessa Laskin

Cancer Care in COVID-19 Era

Featuring:
Dr. Sharlene Gill

Breast Cancer

Featuring:
Dr. Stephen Chia

Supportive Care

Featuring:
Dr. Elie Kassouf

Practice Changing Data

Featuring:
Dr. Kim Ma

Breast Cancer

Featuring:
Dr. Sara Soldera

The Cancer and the Virus: How to Treat One While Keeping the Other One at Bay - The Quebec Strategy

Featuring:
Dr. Jamil Asselah

Breast Cancer

Featuring:
Dr. Sonal Gandhi

Lunch Symposium - Update on Treatments for Advanced RCC: Making Choices Using Script Concordance Theory

Featuring:
Dr. Aly-Khan Lalani

Canadian Achievements in Cancer Research

Featuring:
Dr. Natasha Leighl
Dr. Stephen Chia

CodeBreak 100 & Prevalence of KRASG12C Mutations Utilizing ctCDA

KRAS G12C Mutations

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

KEYNOTE-177 & Pembrolizumab Monotherapy in MSI-H Pts

MSI-H Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

NTRK-FP Solid Tumors - Integrated Analysis & Larotrectinib in Pts with TRK Fusion

NTRK Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

BLU-667 in RET Fusion+ Solid Tumors

RET Fusion+ Solid Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

DESTINY-CRC01

Her-2 Positive Tumors

Featuring:
Dr. Gwyn Bebb
Dr. Philippe Bedard
Dr. Daniel Renouf

S1416

Metastatic Triple Negative Breast Cancer

Featuring:
Dr. Heather McArthur
Dr. Chistine Brezden-Masley
Dr. Christine Simmons

KEYNOTE-355

Metastatic Triple Negative Breast Cancer

Featuring:
Dr. Heather McArthur
Dr. Chistine Brezden-Masley
Dr. Christine Simmons

TRAIN-2

HER2+ Breast Cancer, Neoadjuvant

Featuring:
Dr. Heather McArthur
Dr. Chistine Brezden-Masley
Dr. Christine Simmons

HER2CLIMB

Metastatic HER2+ Breast Cancer

Featuring:
Dr. Heather McArthur
Dr. Chistine Brezden-Masley
Dr. Christine Simmons

KATHERINE & KAITLIN

HER2+ Breast Cancer, Adjuvant

Featuring:
Dr. Heather McArthur
Dr. Chistine Brezden-Masley
Dr. Christine Simmons

ECOG-ACRIN (E2108)

De Novo Stage IV Breast Cancer

Featuring:
Dr. Heather McArthur
Dr. Chistine Brezden-Masley
Dr. Christine Simmons

ASCO20 Virtual Data Watch - Breast Cancers

Lunch Symposium - Implementation of Biosimilars

Featuring:
Dr. Christine Brezden-Masley

Breakfast Symposium - Adjuvant Therapy Advancement - Past, Current and Future

Featuring:
Dr. Karen Gelmon

Breast Cancer

Featuring:
Dr. Chistine Simmons

Breast Cancer Update

Featuring:
Dr. Christine Brezden Masley

Q+A and Case Presentation

Featuring:
Dr. David Hogan and Dr. Adrian Sacher

NTRK: A Transformative New Paradigm in Oncology

Featuring:
Dr. David Hogan

Immune Related Complications From Immune Checkpoint Inhibitors - Cases Discussion Panel,Q&A

Featuring:
Dr. Parneet Cheema

Immune Related Complications From Immune Checkpoint Inhibitors - Patient Monitoring/Patient Tools

Featuring:
Massey Nematollahi

Immune Related Complications From Immune Checkpoint Inhibitors - Dermatologic

Featuring:
Dr. Tom Salopek

Immune Related Complications From Immune Checkpoint Inhibitors - Hepatitis

Featuring:
Dr. Morven Cunningham

Immune Related Complications From Immune Checkpoint Inhibitors - Neurologic

Featuring:
Dr. Dubravka Dodig

Immune Related Complications From Immune Checkpoint Inhibitors - Cases Discussion Panel, Q&A

Featuring:
Dr. Cheema

Immune Related Complications From Immune Checkpoint Inhibitors - Rhematologic

Featuring:
Dr. Raman Joshi

Immune Related Complications From Immune Checkpoint Inhibitors - Nephritis

Featuring:
Dr. Gabrielle Cote

Immune Related Complications From Immune Checkpoint Inhibitors - Pneumonitis

Featuring:
Dr. Shane Shapera

Immune Related Complications From Immune Checkpoint Inhibitors - Diarrhea/Colitis

Featuring:
Dr. Nazira Chatur

Clinical Evidence For Immune-therapies In Practice - Cases Discussion Panel, Q&A

Featuring:
Dr. Rosalyn Juergens

Clinical Evidence For Immune-therapies In Practice - Breast Cancers

Featuring:
Dr. Dave Cescon

Clinical Evidence For Immune-therapies In Practice - Melanoma

Featuring:
Dr. Scott Ernst

Clinical Evidence For Immune-therapies In Practice - Lung Cancers

Featuring:
Dr. Rosalyn Juergens

Clinical Evidence For Immune-therapies In Practice - GI Cancers

Featuring:
Dr. Suneil Khanna

Clinical Evidence For Immune-therapies In Practice - GU Cancers

Featuring:
Dr. Nazanin Fallah-Rad

Principles of Immunotherapeutic Strategies

Featuring:
Dr. Linh Nguyen

The Future of Precision Medicine

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Hormone Receptor Positive Breast Cancer Updates

Featuring:
Dr. Heather McArthur, Dr. Hope Rugo, Dr. Veronique Dieras

HER 2 + Metastatic Breast Cancer Updates

Featuring:
Dr. Heather McArthur, Dr. Hope Rugo, Dr. Veronique Dieras

Targeted therapy and Immunotherapy in Breast Cancer

Featuring:
Dr. Heather McArthur, Dr. Hope Rugo, Dr. Veronique Dieras

Phase I Study of AMG 510

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Abstract 528PD: Correlative analysis of CCTG CO.26

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Abstract LBA30_PR: Correlative analysis of IDEA-FRANCE phase III trial

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

Abstract: LBA15_PR

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

TRK Fusion Updates

Featuring:
Dr. Daniel Renouf, Dr. Jose Monzon, Dr. Jonathan Loree

KEYNOTE-522

Featuring:
Dr. Heather McArthur, Dr. Hope Rugo, Dr. Veronique Dieras

Therapeutic drug monitoring of oral anticancer drugs

Featuring:
Dr. Steffie Groenland
Dr. Neeltje Steeghs

Durvalumab activity in previously treated patients

Featuring:
Dr. Siddharth Sheth

Alliance Trial

Featuring:
Dr. Aranzazu Fernandez Martinez

MAGE-A4 Trial

Featuring:
Dr. Brian Van Tine

HER2-negative metastatic gBRCA associated breast cancer

Featuring:
Dr. Veronique Deiras

KEYNOTE-522 Trial

Featuring:
Dr. Peter Schmid

KATE2 Study

Featuring:
Dr. Leisha Emens

FIGHT-202 Study

Featuring:
Dr. Arndt Vogel

CCGA Study

Featuring:
Dr. Geoffrey Oxnard

Sarcoma

Featuring:
Dr. Christine Simmons

Novel Immune Therapy Approaches: From Immune Checkpoint Inhibitors to Adoptive T-Cell Transfer

Featuring:
Dr. Michael Smylie

Breast Cancer

Featuring:
Dr. Anil Abraham Joy

Canadian Achievements in Cancer Research

Featuring:
Dr. Mark Clemons

Canadian Achievements in Cancer Research

Featuring:
Dr. Lisa Barbera

Breast Cancer

Featuring:
Dr. Dave Cescon

Evidence For NTRK Inhibitors

Featuring:
Dr. David Hong & Dr. Adrian Sacher

Breast Cancer - Adjuvant and Metastatic

Featuring:
Dr. Jamil Asselah

Supportive Care

Featuring:
Dr. Elie Kassouf

New Technologies in Cancer Care

Featuring:
Dr. John Kildea

Hormone Receptor Positive

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Triple Negative Breast Cancer and Immunotherapy

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Updates in Her 2 Positive Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

Broad Indications for Immunotherapy

Featuring:
Dr. Gwyn Bebb
Dr. Daniel Renouf
Dr. Sebastien Hotte

SWOG S1105 Trial

Featuring:
Dr. Dawn Hershman

End of Life Quality at Minority-Serving Cancer Centers

Featuring:
Dr. Garrett Wasp

Monteluksat and Rupatadine and their combination with Rituximab

Featuring:
Dr. Rouslan Kotchetkov

Routine ESAS use on OS

Featuring:
Dr. Lisa Barbera

What is the Role of 'Big Data' in Cancer Care

Featuring:
Cindy Perettie, CEO, Foundation Medicine Inc.

Panel Discussion

Future of Precision Medicine

Featuring:
Dr. Trevor Pugh

The Impact of Artificial Intelligence and 'Big Data' on Health Policy

Featuring:
Dr. Catherine Stinson

BioInformatics and the Role of Artificial Intelligence in Cancer Care

Featuring:
Dr. Benjamin Haibe-Kains

How is Technology Impacting Drug Development in Oncology

Featuring:
Dr. Leigh Revers

Panel Discussion

Featuring:
Dr. Sunil Verma, Dr. Sonal Gandhi, & Dr. Rossanna Pezo

Lunch Presentation - Biosimilars in Oncology

Featuring:
Dr. Anil Abraham Joy
Dr. Sandeep Sehdev

Special Session: Best of Real World Evidence in Oncology

Featuring:
Dr. Winson Cheung

Breast Cancer

Featuring:
Dr. Karen Gelmon

HER2 Positive Breast Cancer

Featuring:
Dr. Sunil Verma

ER Positive Breast Cancer

Featuring:
Dr. Rossanna Pezo

Tackling Toxicity Management

Featuring:
Dr. Sonal Gandhi & Alia Thawer, Pharmacist

Keynote Lecture: Hormone Receptor Positive Breast Cancer: Personalized Approach and the Road ahead

Featuring:
Dr. Sara Tolaney

Lunch Symposium - Biosimilars in Breast Cancer

Featuring:
Dr. Sunil Verma & Dr. Sandy Sehdev

Debate: Role of Next Generation Sequencing Should Be Done On Metastatic Breast Cancer Patients

Featuring:
Dr. Christine Simmons vs. Dr. Dave Cescon

Breast Cancer Case Discussion

Featuring:
Dr. Vivian Glenns, Dr. Rosanna Pezo, Dr. Sonal Gandhi, & Dr. Dave Cescon

Triple Negative Breast Cancer

Featuring:
Dr. Dave Cescon

Key Breast Cancer Trials in the GTA

Featuring:
Dr. Dave Cescon

Roundtable Discussion - Hormone Receptor Positive Breast Cancer

Featuring:
Dr. Christine Simmons, Dr. Sara Tolaney, & Dr. Sunil Verma

Roundtable Discussion - HER2 Positive Breast Cancer

Featuring:
Dr. Christine Simmons, Dr. Sara Tolaney, & Dr. Sunil Verma

Roundtable Discussion - Triple Negative Breast Cancer

Featuring:
Dr. Christine Simmons, Dr. Sara Tolaney, & Dr. Sunil Verma

Best of Oncology East 2018

November 30th, 2018
Toronto, ON

Satellite Symposium - Lunch Presentation - Chemotherapy-Induced Nausea and Vomiting — A Case-Based Presentation

Featuring: Dr. Kasia Jerzak
Shikha Lawrence

Best of Oncology East 2018 - Breast Cancer

Featuring:
Dr. Dave Cescon

Biomarkers to Guide Treatment Decision: PDL-1 and Beyond

Featuring:
Dr. Ming Tsao

CAR T-Cell Therapy: Are we driving in the fast lane?

Featuring:
Dr. Christine Chen

Clinical Evidence for Immuno-Therapies in Practice in Breast Cancer

Featuring:
Dr. Sunil Verma

Innovating Clinical Trial Designs to accelerate Immune-Therapies in Cancer

Featuring:
Dr. Martin Smoragiewicz

Combination Strategies to Enhance Efficacy

Featuring:
Dr. Adrian Sacher

Panel Discussion

Featuring:
Dr. Martin Smoragiewicz
Dr. Christine Chen
Dr. Adrian Sacher

The Future of IO Therapies Beyond Checkpoint Inhibitors

Featuring:
Dr. Rosalyn Juergens

Panel Discussion

Featuring:
Dr. Natasha Leighl
Dr. Henry Conter
Dr. Sunil Verma

The Canadian Advantage – Role of Real World Evidence and Opportunities to Enhance Value of IO Therapies in Canada

Featuring:
Dr. Natasha Leighl

Case Studies and Panel Discussion

Featuring:
Dr. Andrew Robinson
Dr. Nancy Nixon
Dr. David Hogg
Dr. Teresa Petrella

Role of Multi-Disciplinary Team in Management of Patients on IO Therapies

Featuring:
Dr. David Hogg

Keynote Lecture: Personalizing Immune-Therapies and Understanding resistance

Featuring:
Dr. David Carbone

Canadian Immuno-Oncology Summit 2018

November 1st, 2018
Toronto, ON

Updates from Day 1 of ESMO 2018

Featuring:
Dr. Sunil Verma

IMpassion 130 Trial

Featuring:
Dr. Peter Schmid

Updates from Day 2 of ESMO 2018

Featuring:
Dr. Sunil Verma

20 yr update N4+ Study

Featuring:
Dr. Tessa Steenbruggen

Transtuzumab + Neuvax Vs Transtuzamb in TNBC Patients

Featuring:
Dr. Diane Hale

Initial of BMS-986158 in Phase 1 dose escalation

Featuring:
Dr. John Hilton

PHOENIX Study

Featuring:
Dr. Ali Alkan

AMC303

Featuring:
Dr. Emiliano Calvo

Probiotics in Chemo-induced Diarrhea

Featuring:
Dr. Atul Sharma

Updates in Triple Negative Breast Cancer

Featuring:
Dr Sunil Verma
Dr Hope Rugo
Dr Peter Schmid

Updates in HR+ Positive Breast Cancer

Featuring:
Dr Sunil Verma
Dr Hope Rugo
Dr Peter Schmid

Updates in HER2+ Positive Breast Cancer

Featuring:
Dr Sunil Verma
Dr Hope Rugo
Dr Peter Schmid

TILs in ShortHER Trial

Featuring:
Dr. Maria Dieci

NETSARC Study

Featuring:
Dr. Jean-Yves Blay

Panel Discussion

Featuring:
Dr. David Carbone
Dr. Rosalyn Juergens
Dr. Teresa Petrella
Dr. Ming Tsao
Dr. Sunil Verma

Cost of integrating Immuno-Oncology Therapy in Clinical Practice: Are we prepared?

Featuring:
Dr. Henry Conter

Special Session: Precision Oncology

Featuring:
Dr. Gwyn Bebb

Best of ASCO Vancouver 2018 - Breast Cancer

Featuring:
Dr. Stephen Chia

Lunch Symposium - New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Jay Easaw and Roland Coppens

Canadian Achievements in Cancer Research, TAILORx

Featuring:
Dr Kathleen Pritchard

New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Jay Easaw & Mark Pasetka

Best of ASCO Toronto 2018 - Breast Cancer

Featuring:
Dr. Dave Cescon

New Guidelines and Optimizing the Management of Chemotherapy-Induced Nausea and Vomiting

Featuring:
Dr. Nathaniel Bouganim and Veronique Savard

Best of ASCO Montreal 2018 - Supportive Care

Featuring:
Dr. Elie Kassouf

Best of ASCO Montreal 2018 - Breast Cancer - Adjuvant & Metastatic

Featuring:
Dr. Wilson Miller

Updates in HER2+ Breast Cancer

Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Updates in Triple Negative Breast Cancer

Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Updates from Metastatic Breast Cancer Oral Abstract and Plenary Sessions

Featuring:
Dr. Sunil Verma

PAKT Trial

Featuring:
Dr. Peter Schmid

ASTRRA Study

Featuring:
Dr. Noh Woochul

Results from the TEXT and SOFT Trials

Featuring:
Dr. Meredith Regan

TONIC Trial

Featuring:
Dr. Marleen Kok

ABCSG-18 Adjuvant Denosumab DFS Analysis

Featuring:
Dr. Michael Gnant

Proactive Symptom Assessment Effect on Care Outcomes

Featuring:
Dr. Manali Patel

HER2-Targeted Topo Inhibition in HER2+ Solid Tumours

Featuring:
Dr. Hiroji Iwata

PIVOT Trial

Featuring:
Dr. Adi Diab

Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers

Featuring:
Dr. Julius Strauss

MATCH Study

Featuring:
Dr. Young Kwang Chae

Duplicate of Proactive Symptom Assessment Effect on Care Outcomes

Featuring:
Dr. Manali Patel

Duplicate of HER2-Targeted Topo Inhibition in HER2+ Solid Tumours

Featuring:
Dr. Hiroji Iwata

Duplicate of PIVOT Trial

Featuring:
Dr. Adi Diab

Duplicate of Bidirectional Targeting of PD-L1 and TNFb in HPV-Associated Cancers

Featuring:
Dr. Julius Strauss

Duplicate of MATCH Study

Featuring:
Dr. Young Kwang Chae

Updates in HR+ Breast Cancer

Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Mutational Signatures in BrCa

Featuring:
Dr. Romualdo Barroso De Sousa

Targeted Antibody Conjugate in HER2 Amplified Cancers

Featuring:
Dr. Bob Li

Duplicate of Targeted Antibody Conjugate in HER2 Amplified Cancers

Featuring:
Dr. Bob Li

Introduction to BRCA Testing

Featuring:
Dr. Intan Schrader

PARP Inhibitors in Breast Cancer

Featuring:
Dr. Karen Gelmon

BRCA Testing and PARP Inhibitors in Breast Cancer - Panel Discussion

Featuring:
Dr. Sunil Verma
Dr. Karen Gelmon
Dr. Intan Schrader

Key Breast Cancer Trials in the Greater Toronto Area

Featuring:
Dr. Ellen Warner and Dr. Dave Cescon

Panel Discussion on Biosimilars

Featuring:
Dr. Scott Berry
Flay Charbonneau
Alexandra Chambers
Dr. Andrea Eisen
Dr. Hal Hirte
Dr. Sunil Verma
Dr. Sandy Sehdev
Barry Stein

From Bench to Bedside with Bevacizumab Biosimilars

Featuring:
Dr. Scott Berry

Biosimilars in Breast Cancer: Clinical Implications

Featuring:
Dr. Sunil Verma

Update from CADTH on Biosimilars

Featuring:
Alexandra Chambers
‎Director, pan Canadian Oncology Drug Review (pCODR), CADTH

Understanding the Science of Biosimilars: How are they different from emerging drugs? What are they and how are they created?

Featuring:
Dr. Sandy Sehdev

Best of Oncology East 2017 - Breast Cancer

Featuring:
Dr. Dave Cescon

Updates in HR+ Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Updates in HER2+ Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo

Updates in Triple Negative Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Video 1: Introduction to Biosimilars

Updates in HER2+ Breast Cancer - Day 1

Featuring:
Dr. Sunil Verma

Updates in Triple Negative Breast Cancer - Day 2

Featuring:
Dr. Sunil Verma

Updates in HR+ Breast Cancer - Day 1

Featuring:
Dr. Sunil Verma

Updates in HR+ Breast Cancer - Day 2

Featuring:
Dr. Sunil Verma

Updates in Triple Negative Breast Cancer - Day 1

Featuring:
Dr. Sunil Verma

Updates in HER2+ Breast Cancer - Day 2

Featuring:
Dr. Sunil Verma

Video 4: Biosimilars in Clinical Practice Panel Discussion

Featuring:
Dr. Scott Berry
Dr. Sunil Verma
Dr. Sandy Sehdev

Video 3: Bevacizumab Biosimilars Clinical Considerations

Featuring:
Dr. Scott Berry

Video 2: Trastuzumab Biosimilars Clinical Considerations

Featuring:
Dr. Sunil Verma

Special Session - Biosimilars

Featuring:
Dr. Sunil Verma

Best of Oncology West 2018 - Breast Cancer

Featuring:
Dr. Anil Joy

HER2 Positive Breast Cancer

Featuring:
Dr. Sunil Verma

Triple Negative Breast Cancer

Featuring:
Dr. John Hilton

Keynote Lecture: Individualizing the treatment for Breast Cancer in Young Women

Featuring:
Dr. Ann Partridge

Quality and Safety: A Focus on Oral Drugs

Featuring:
Dr. Sonal Gandhi

Hormone Receptor Positive Breast Cancer

Featuring:
Dr. Maureen Trudeau

Prioritizing Patient Voice in Breast Cancer

Featuring:
Dr. Nancy Nixon

Radiation Oncology Highlights

Featuring:
Dr. Eileen Rakovitch

Surgical Oncology Highlights

Featuring:
Dr. Tulin Cil

Neoadjuvant Treatment Highlights

Featuring:
Dr. Sonal Gandhi

Biology and Pathology

Featuring:
Dr. Sharon Nofech-Mozes

Case-Based Discussion in Early Breast Cancer

Featuring:
Dr. Orit Freedman

Novel Targets and Treatments in Breast Cancer

Featuring:
Dr. Dave Cescon

Canadian Cancer Trials Group - MA.17R Study Commentary

Featuring:
Dr. Wendy Parulekar

New Targets in ER+/HER2- mBC: Where Are We Today? Question & Answer Period

Featuring:
Dr. Richard Finn

New Targets in ER+/HER2- mBC: Where Are We Today?

Featuring:
Dr. Richard Finn

Cancer Cell Line Panels

Featuring:
Dr. Dennis Slamon

Overview of CDK4/6 Inhibitors

Featuring:
Dr. Dennis Slamon

Clinical Translation of Palbociclib

Featuring:
Dr. Dennis Slamon

Clinical Translation of Other CDK4/6 Inhibitors

Featuring:
Dr. Dennis Slamon

Case Presentation

Featuring:
Dr. Dennis Slamon

From Bench to Bedside: Translating New Knowledge to Drug Development

Featuring:
Dr. Linh Nguyen

From Bedside to Bench – Understanding Immune-Therapy Resistance

Featuring:
Dr. Jason Luke

Biomarkers to Guide IO Therapy

Featuring:
Dr. Rosalyn Juergens

PD-L1 Testing in Routine Practice

Featuring:
Dr. Ming Tsao

Management of Immune-Therapy Related Adverse Events

Featuring:
Dr. David Hogg

Utilizing Immuno-Oncology Therapies in Clinical Practice

Featuring:
Dr. Michael Smylie

Beyond Checkpoint Inhibitors – Novel IO Therapies and IO-IO Combination Therapy

Featuring:
Dr. Jason Luke

IO Combination with Chemotherapy, Radiation and Targeted Therapies

Featuring:
Dr. Heather McArthur

Immunotherapy in Breast Cancer

Featuring:
Dr. Heather McArthur

Video 1: Advances in HR+ Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Video 2: Advances in HER2+ Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Video 3: Advances in Triple Negative Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Hope Rugo
Dr. Peter Schmid

Key Breast Cancer Highlights - Day 1

Featuring:
Dr. Sunil Verma

Key Breast Cancer Highlights - Day 2

Featuring:
Dr. Sunil Verma

Key Breast Cancer Highlights - Day 3

Featuring:
Dr. Sunil Verma

KEYNOTE-086 Trial

Featuring:
Dr. Sherene Loi

EORTC 10041/BIG 3-04 (MINDACT) Substudy

Featuring:
Dr. Konstantinos Tryfonidis

LORELEI Study

Featuring:
Dr. Cristina Saura, MD

Denosumab in Giant Cell Tumor of Bone

Featuring:
Dr. Emanuela Palmerini

Nivolumab & ISA 101 HPV vaccine in incurable HPV-16+ cancer

Featuring:
Dr. Erminia Massarelli

Antivascular Tumour Therapy

Featuring:
Dr. Urban Emmenegger

Molecular Targeting and Drug Design

Featuring:
Dr. Aaron Schimmer

New Targets in ER+/HER2- mBC: Where Are We Today?

Featuring:
Dr. Richard Finn
November 21st, 2017

Video 3:
Updates in Triple Negative Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Peter Schmid
Dr. Richard Finn

Video 1:
Updates in HR+ Breast Cancer

Featuring:
Dr. Sunil Verma
Dr. Peter Schmid
Dr. Richard Finn

Video 2:
Updates in HER2+ Breast Cancer in the Early Stage Setting

Featuring:
Dr. Sunil Verma
Dr. Peter Schmid
Dr. Richard Finn

Chicago 2017: Breast Cancer Round Table

June 2-6, 2017
Chicago, USA

APHINITY Trial

Featuring:
Dr. Gunter Von Minckwitz

SOLE Trial

Featuring:
Dr. Marco Colleoni

Targeted Sequencing of Luminal Breast Cancer

Featuring:
Dr. John Barlett

PlanB Trial

Featuring:
Dr. Oleg Gluz

SHORT-HER Trial

Featuring:
Dr. Pier Franco Conte

Key Updates in Metastatic Breast Cancer

Featuring:
Dr. Sunil Verma

Key Updates in Breast Cancer - Day 2

Featuring:
Dr. Sunil Verma

Updates from Chicago 2017: Other Topics

June 3-7, 2017
Chicago, USA

Canadian Achievements in Cancer Research

Featuring:
Dr. Monika Kryzyzanowska

Canadian Achievements in Cancer Research

Featuring:
Sierra Cheng

Best of ASCO Toronto 2017 - Breast Cancer

Featuring:
Dr. Maureen Trudeau

Best of ASCO Montreal 2017 - Breast Cancer: Neoadjuvant

Featuring:
Dr. Rami Younan

Best of ASCO Montreal 2017 - Breast Cancer: Adjuvant and Metastatic

Featuring:
Dr. Jamil Asselah

Best of ASCO Montreal 2017 - Canadian Abstracts

Featuring:
Dr. Kim Ma

Health Sciences Research: Patient Reported Outcomes

Featuring:
Dr. Robert Olson

Best of ASCO Vancouver 2017 - Breast Cancer

Featuring:
Dr. Sunil Verma

Hormone Receptor Positive Breast Cancer

Featuring:
Dr. Maureen Trudeau

HER2 Positive Breast Cancer

Featuring:
Dr. Sunil Verma

Neoadjuvant Treatment of Breast Cancer

Featuring:
Dr. Christine Brezden-Masley

Panel Discussion 1L: HR+, HER2+, and Neoadjuvant Treatment Insights

Featuring:
Dr. Sunil Verma
Dr. Christine Brezden-Masley
Dr. Maureen Trudeau

Keynote Presentation

Funding and Reimbursement at Cancer Care Ontario and…

Featuring:
Dr. Andrea Eisen

Radiation Oncology Highlights

Featuring:
Dr. Eileen Rakovitch

Surgical Oncology Highlights

Featuring:
Dr. Jean-Francois Boileau

Biology and Pathology Insights

Featuring:
Dr. John Bartlett

Panel Discussion: Surgery and Pathology Insights

Featuring:
Dr. Jean-Francois Boileau
Dr. John Bartlett

Triple Negative Breast Cancer

Featuring:
Dr. Dave Cescon

Novel Targets and Therapies in Breast Cancer

Featuring:
Dr. John Hilton

Panel Discussion 3

Triple Negative and Novel Targets/Therapy Insights

Featuring:
Dr. Dave Cescon
Dr. John Hilton

Round Table Discussion: Key Highlights in Breast Cancer from 2016

Featuring:
Dr. Sunil Verma
Dr. Christine Brezden-Masley
Dr. John Hilton

Best of Oncology East 2016 - Breast Cancer

Featuring:
Dr. Mark Clemons

Debate on Second Entry Biologic

Featuring:
PRO: Dr. Leigh Revers
CON: Dr. Sandy Sehdev

Promises and Challenges in Immuno-Oncology

Featuring:
Dr. Réjean Lapointe

Principles of Immuno-Oncology - A Clinician Perspective

Featuring:
Dr. Omid Hamid

Round Table Discussion: Breast Cancer Highlights from ESMO 2016

Featuring:
Dr. Sunil Verma
Dr. Christine Brezden-Masley
Dr. Peter Schmid

MCBS in rare tumor entities

Featuring:
Dr. Barbara Kiesewetter

FALCON Trial

Featuring:
Dr. Matthew Ellis

Interim results from neoMONARCH

Featuring:
Dr. Sara Hurvitz

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors

Featuring:
Dr. Catharina Menke-van der Houven van Oordt

BAY 1163877

Featuring:
Dr. Markus Joerger

BOLERO-4 trial

Featuring:
Dr. Fatima Cardoso

PM01183 in BRCA1/2 Metastatic Breast Cancer

Featuring:
Dr. Judith Balmana

PRIME-NET study

Featuring:
Dr. Sara Pusceddu

FALCON Trial

Featuring:
Dr. Sunil Verma

Phase 3 PALOMA-2 Trial

Featuring:
Dr. Richard Finn

MONALEESA-2 Trial

Featuring:
Dr. Sunil Verma

Tumour gene expression data and clinical decision-making for patients with advanced cancers

Featuring:
Dr. Janessa Laskin

Trabectedin vs best supportive care in pretreated advanced soft tissue sarcoma

Featuring:
Dr. Axel Le Cesne

Lunch Symposium: Urothelial Cancers Management

Featuring:
Dr. Robert Dreicer

Round-Table Discussion on Pharmacoeconomics

Featuring:
Dr. Kathleen Barnard, Dr. Brent Fraser, Dr. Jaclyn Beca, Dr. Marcus Butler & Dr. Ilias Illiopolous
Chair: Dr. Sunil Verma

Keynote Presentation: Future Applications in Immuno-Oncology

Featuring:
Dr. Jason Luke

A New Way of Treating: Multidisciplinary Approach in Immuno-Therapy

Featuring:
Dr. David Hogg

Panel Discussion: Redefining Success in Oncology

Featuring:
Dr. Jason Luke, Kathleen Barnard, Christina Sit & Dr. Marcus Butler
Moderator: Dr. Rosalyn Juergens

Plenary Session Q&A

Featuring:
Dr. Jason Luke, Kathleen Barnard, Dr. Marcus Butler & Dr. Linh Nguyen
Chair: Dr. Sunil Verma

Immuno-Oncology: From Concept to Reality

Featuring:
Dr. Jason Luke

Beyond the Curve

Featuring:
Kathleen Barnard

Principles of Immuno-Oncology - An Immunologist Perspective

Featuring:
Dr. Linh Nguyen

Lorazepam as an Adjuvant to Haloperidol for Agitated Delirium at the End of Life

Featuring:
Dr. David Hui

CALM Trial

Featuring:
Dr. Gary Rodin

Psychological Intervention on the Fear of Cancer

Featuring:
Dr. Jane Beith

Korean Red Ginseng to Improve Cancer-Related Fatigue

Featuring:
Dr. Yeul Hong Kim

Immune response, safety, and survival impact in soft tissue sarcomas

Featuring:
Dr. Neeta Somaiah

Laboratory Methods in Translational Oncology Research

Featuring:
Dr. Kelsie Thu

Keynote Address: The Important Molecular/ Translational Endpoints In Clinical Trials

Featuring:
Dr. Kathy Pritchard

DNA Repair and Epigenetics

Featuring:
Dr. Rosalyn Juergens

Oncogenes/Tumour Suppressor Genes

Featuring:
Dr. Neesha Dhani

Signaling Pathways

Featuring:
Dr. Tony Mutsaers

Cell Cycle and Survival Mechanisms

Featuring:
Dr. David Cescon

Stem Cells

Featuring:
Dr. Catherine O'Brien

Tumour Immunobiology/ Immunotherapy

Featuring:
Dr. Marcus Butler

Invasion Metastasis

Featuring:
Dr. Richard Hill

Molecular Pathology

Featuring:
Dr. Ming Tsao

An Introduction to Biomarkers

Featuring:
Dr. Phil Bedard

Molecular Pharmacology/ Epidemiology

Featuring:
Dr. Geoff Liu

Best of ASCO Vancouver 2016 - Breast Cancer

Featuring:
Dr. Sunil Verma

Canadian Achievements in Cancer Research

Featuring:
Dr. Kathy Pritchard

Best of ASCO Toronto 2016 - Breast Cancer

Featuring:
Dr. David Cescon

Best of ASCO Montreal 2016 - Neuroendocrine Cancers

Featuring:
Dr. Simron Singh

Best of ASCO Montreal 2016 - Breast Cancer (Français): Part 1

Featuring:
Dr. Jamil Asselah

Best of ASCO Montreal 2016 - Breast Cancer (Français): Part 2

Featuring:
Dr. André Robidoux

Webinar Archive: Live from Chicago 2016 - Breast Cancer Updates

Featuring:
Dr. Sunil Verma

Highlights on Cancer and the Heart ASCO 2016

Featuring:
Dr. Susan Dent

Joint Analysis of the ABC Phase III Trials

Featuring:
Dr. Joanne Blum

KRISTINE Trial

Featuring:
Dr. Sara Hurvitz

Phase I study of sapacitabine and seliciclib

Featuring:
Dr. Sara Tolaney

Comorbidities & Risk of Peripheral Neuropathy in SWOG Trials

Featuring:
Dr. Dawn Hershman

PALOMA-2 Trial

Featuring:
Dr. Richard Finn

Phase 1B Study of BGJ398 with BYL719

Featuring:
Dr. David Hyman

Canadian Cancer Trials Group - MA.17R Study

Featuring:
Dr. Sunil Verma

Case Study #1

Featuring:
Dr. Danielle Charpentier

Case Study #2

Featuring:
Dr. Alexis Charest-Marcotte

Genomics to Personalize Therapy of Patients with Metastatic Breast Cancer

Featuring:
Dr. Fabrice André

Targeted Therapies in ER+ Metastatic Breast Cancer Patients

Featuring:
Dr. Fabrice André

Targeted Therapies in ER+ Metastatic Breast Cancer Patients

Featuring:
Dr. Fabrice André

Protocol MF07-01 Trial

Featuring:
Dr. Atilla Soran

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy

Featuring:
Dr. Ian Kleckner

Breast Cancer Highlights

Featuring:
Dr. Sunil Verma

Precision Medicine in Cancer Care

Featuring:
Dr. Jonathan Trent

Breast Updates

Featuring:
Dr. Artur Katz

Webinar Archive: NETs Speaker Tour Montreal

Featuring:
Dr. Simron Singh

NETs Case Study

Featuring:
Dr. Petr Kavan

NETs in Québec

Featuring:
Dr. Albert Moghrabi

What's New with NETs?

Featuring:
Dr. Simron Singh

Best of Oncology West 2017 - Supportive Care

Featuring:
Dr. Corey Metcalf

Best of Oncology West 2017 - Breast Cancer

Featuring:
Dr. Stephen Chia

Webinar Archive: NETs Speaker Tour Vancouver

Featuring:
Dr. Simron Singh
Dr. John Paul McGhie
Dr. Hagen Kennecke

NET Case Study

Featuring:
Dr. Hagen Kennecke

BC Perspective on NETs

Featuring:
Dr. John Paul McGhie

What's New With NETs?

Featuring:
Dr. Simron Singh

Webinar Archive: NETs Speaker Tour Toronto

Featuring:
Dr. Simron Singh
Dr. Calvin Law
Dr. Tim Asmis

Neuroendocrine Cancers: What's New With NETs?

Featuring:
Dr. Simron Singh

Advanced NETs

Featuring:
Dr. Calvin Law

Non-Functioning Small pNETS

Featuring:
Dr. Tim Asmis

Recent Videos

Popular Videos